Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.14% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
TransAlta
TAC
$3.99B
| $44.2M | ﹤0.01% |
3,497,528
-4,594,201
| -57% | -$68.6M |
|
2202
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$6.12B
| $44.2M | ﹤0.01% |
1,508,707
+10,868
| +0.7% | +$318K |
|
2203
BlackRock Debt Strategies Fund
DSU
$600M
| $44.1M | ﹤0.01% |
4,334,732
+348,619
| +9% | +$3.59M |
|
|
CSGS
2204
DELISTED
CSG Systems International
CSGS
| $44.1M | ﹤0.01% |
575,019
+255,550
| +80% | +$18.9M |
|
2205
Vipshop
VIPS
$6.8B
| $44.1M | ﹤0.01% |
2,491,632
-1,136,959
| -31% | -$21.9M |
|
2206
CVB Financial
CVBF
$4.08B
| $44.1M | ﹤0.01% |
2,369,413
+288,379
| +14% | +$5.52M |
|
2207
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.27B
| $44.1M | ﹤0.01% |
1,899,820
-344,857
| -15% | -$8.02M |
|
2208
CryoPort
CYRX
$766M
| $44M | ﹤0.01% |
4,587,544
-23,463
| -0.5% | -$222K |
|
2209
State Street SPDR NYSE Technology ETF
XNTK
$2.27B
| $44M | ﹤0.01% |
158,330
+7,967
| +5% | +$2.23M |
|
2210
Argan
AGX
$7.84B
| $43.9M | ﹤0.01% |
140,169
-330
| -0.2% | -$105K |
|
|
PONY
2211
Pony AI Inc
PONY
$3.62B
| $43.9M | ﹤0.01% |
3,024,346
-285,956
| -9% | -$4.75M |
|
2212
BlackRock Resources & Commodities Strategy Trust
BCX
$961M
| $43.8M | ﹤0.01% |
3,992,507
+800,982
| +25% | +$8.22M |
|
|
SCHR
2213
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
| $43.8M | ﹤0.01% |
1,747,388
+404,534
| +30% | +$10.2M |
|
|
STEW
2214
SRH Total Return Fund
STEW
$1.8B
| $43.8M | ﹤0.01% |
2,362,659
+5,013
| +0.2% | +$90.1K |
|
2215
Sabesp
SBS
$16.5B
| $43.8M | ﹤0.01% |
9,193,005
+1,152,197
| +14% | +$5.56M |
|
|
THR
2216
DELISTED
Thermon Group Holdings
THR
| $43.7M | ﹤0.01% |
1,175,768
+456,243
| +63% | +$15M |
|
2217
Comstock Resources
CRK
$3.99B
| $43.7M | ﹤0.01% |
1,883,337
+41,021
| +2% | +$904K |
|
2218
Chesapeake Utilities
CPK
$3.26B
| $43.6M | ﹤0.01% |
349,233
+15,746
| +5% | +$2.08M |
|
2219
CarGurus
CARG
$3.38B
| $43.6M | ﹤0.01% |
1,135,905
+232,918
| +26% | +$8.39M |
|
2220
Dentsply Sirona
XRAY
$2.31B
| $43.4M | ﹤0.01% |
3,794,956
+929,057
| +32% | +$10.9M |
|
2221
Adams Diversified Equity Fund
ADX
$3.3B
| $43.3M | ﹤0.01% |
1,858,871
-504,785
| -21% | -$11.6M |
|
2222
IDEAYA Biosciences
IDYA
$3.53B
| $43.3M | ﹤0.01% |
1,252,404
-327,949
| -21% | -$10.5M |
|
2223
Glacier Bancorp
GBCI
$6.48B
| $43.2M | ﹤0.01% |
979,812
-27,111
| -3% | -$1.19M |
|
2224
Cellebrite
CLBT
$2.69B
| $43.1M | ﹤0.01% |
2,390,114
-492,232
| -17% | -$8.84M |
|
2225
WisdomTree Managed Futures Strategy Fund
WTMF
$250M
| $43M | ﹤0.01% |
1,130,590
+5,391
| +0.5% | +$206K |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,946 increased, 2,962 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.